Element Capital Management’s Bio-Techne TECH Stock Holding History

Element Capital Management’s Portfolio TECH Stock Details TECH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-9,057	Closed	-$617K	–	199
2023 Q3	$617K	Sell	9,057 -12,619	-58%	-$997K	0.05%	208
2023 Q2	$1.77M	Buy	21,676 +1,124	+5%	+$90.3K	0.12%	180
2023 Q1	$1.52M	Buy	+20,552	New	+$1.58M	0.12%	135
2018 Q4	–	Sell	-6,424	Closed	-$328K	–	877
2018 Q3	$328K	Buy	+6,424	New	+$285K	0.01%	562

Other funds holding TECH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return

DDC

DF Dent & Co Baltimore, Maryland $5.27B AUM 7.89% 1-Year Est. Return

Element Capital Management's TECH Position: Q4 2023 in Review

Element Capital Management sold out of Bio-Techne (TECH) in Q4 2023, closing a stake of 9,057 shares — an estimated $617K sold.

Element Capital Management first reported a position in TECH in Q3 2018 and held it in 4 quarters. The position peaked at $1.77M in Q2 2023. 531 funds tracked by Wall St. Rank hold TECH as of Q4 2023.

Element Capital Management reported no remaining Bio-Techne position as of Q4 2023 after selling out during the quarter.
Element Capital Management sold 9,057 Bio-Techne shares in Q4 2023, an estimated $617K.
Element Capital Management first reported a position in Bio-Techne in Q3 2018 and held it in 4 quarters.
Element Capital Management's Bio-Techne position peaked at $1.77M in Q2 2023.
531 funds tracked by Wall St. Rank held Bio-Techne as of Q4 2023.

Based on Element Capital Management's 13F filing for Q4 2023, filed 9 Feb 2024.